Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 184   

Articles published

PFE 35.09 +0.25 (0.72%)
price chart
Pfizer Inc. (NYSE:PFE): Analyst is Neutral to Positive on Medivation Inc ...
BMO Capital analyst offered commentary on Pfizer Inc. (NYSE:PFE) soon after the company announced Medivation Inc (NASDAQ:MDVN) acquisition valued at $14 billion.
Pfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring  Profit Confidential
Most Recent analysts Ratings: Pfizer, Inc. (NYSE:PFE)
Pfizer, Inc. (NYSE:PFE) reported its last earnings on Aug 02 BMO (BMO = before market open, AMC= after market close).
Analysts Tips to Monitor: Pfizer, Inc. (NYSE:PFE) , SCYNEXIS, Inc. (NASDAQ:SCYX)  Street Updates
23andMe Gene Database Receives Increased Demand Following Pfizer Inc. (NYSE ...
Pfizer Inc. (NYSE:PFE) recently used the 23andMe gene database to identify 15 genome sites linked with depression. 23andME is currently reporting an increased demand to access its personal genetics pioneer's repository.
BMO Capital Highlights Several Targets Following Pfizer Inc.'s Deal with ...
Considering Pfizer Inc.'s (NYSE:PFE) deal worth $14 billion in order to acquire Medivation Inc (NASDAQ:MDVN), analyst Do Kim at BMO Capital believes the deal has increased the attractiveness of the other mid-cap companies in the bio-tech segment.
Pfizer, Target, JC Penney: Fast Money Picks For August 23
On CNBC's Fast Money Final Trade, Pete Najarian said he is a buyer of Pfizer Inc. (NYSE: PFE). He thinks it's going higher, because it has a great pipeline.
Pfizer, Inc. (NYSE:PFE) Updated Price Targets
08/22/2016 - Pfizer, Inc. had its “outperform” rating reiterated by analysts at BMO Capital Markets. They now have a USD 40 price target on the stock.
Pfizer Inc. (PFE) Given a $40.00 Price Target by Bank of America Corp. Analysts
Pfizer Inc. logo Bank of America Corp. set a $40.00 price target on Pfizer Inc. (NYSE:PFE) in a research report report published on Monday.
Piper Jaffray Cos. Analysts Give Pfizer Inc. (PFE) a $54.00 Price Target  BBNS
Momentum Stocks: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Pfizer Inc ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) went down -1.54% or -0.45 points to reach at $28.74 during the course of previous trade.
Healthcare Movers: Valeant Pharmaceuticals (NYSE:VRX), EnteroMedics (NASDAQ ...  Benchmark Monitor
Pfizer close to buying Medivationl, ChemChina gets US nod for Syngenta deal
Pfizer Inc (NYSE:PFE) is at the centre of another big drugs deal according a number of press reports linking it to a US$14bn takeover of Medivation Inc (NASDAQ:MDVN).
Pfizer Inc. (PFE) Closes 0.4% Down on the Day for August 22
Pfizer Inc. currently has a total float of 6.07 billion shares and moves 19.2 million a day, on average. The stock opened at $34.80 on August 22 and traded between a low of $34.76 and a high of $35.28.